Overview
Tetanus Immune Globulin is manufactured from human plasma . It contains antibodies against tetanus toxoid and is primarily used as prophylaxis against tetanus in wounded patients.
Indication
For use as prophylaxis against tetanus in patients who are injured and have incomplete of uncertain immunization status . May also be used in the treatment of active tetanus.
Associated Conditions
- Tetanus
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2007/02/21 | Phase 4 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| HyperTET S/D Injection 250 units | SIN09656P | INJECTION | 250 units | 2/26/1998 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| CSL TETANUS IMMUNOGLOBULIN-VF (human) for intravenous use 4000IU injection vial | 31829 | Medicine | A | 11/4/1991 | |
| CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial | 125817 | Medicine | A | 3/1/2006 | |
| CSL TETANUS IMMUNOGLOBULIN VF (human) 250IU injection vial | 61218 | Medicine | A | 10/21/1998 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| HYPERTET S/D | 02379619 | Solution - Intramuscular | 250 UNIT / DOSE | N/A | |
| HYPERTET S/D | 02230697 | Solution - Intramuscular | 250 UNIT / DOSE | 7/8/1997 | |
| HYPERTET | 02520087 | Solution - Intramuscular | 250 UNIT / ML | 12/13/2021 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.